NEKTAR THERAPEUTICS Insider Trading for December 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEKTAR THERAPEUTICS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NEKTAR THERAPEUTICS for December 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 20 2019 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | M | 9.24 | 10,000 | 92,400 | 30,000 | |
| Dec 20 2019 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Buy | M | 9.24 | 10,000 | 92,400 | 198,250 | 188.3 K to 198.3 K (+5.31 %) |
| Dec 16 2019 | NKTR | NEKTAR THERAPEUTIC ... | Myriam Curet | Director | Option Exercise | A | 21.79 | 23,400 | 509,886 | 23,400 | |
| Dec 16 2019 | NKTR | NEKTAR THERAPEUTIC ... | Myriam Curet | Director | Grant | A | 0.00 | 11,700 | 0 | 11,700 | 0 to 11.7 K |
| Dec 16 2019 | NKTR | NEKTAR THERAPEUTIC ... | Zalevsky Jonathan | Chief R&D Officer | Option Exercise | A | 21.79 | 20,100 | 437,979 | 20,100 | |
| Dec 16 2019 | NKTR | NEKTAR THERAPEUTIC ... | Zalevsky Jonathan | Chief R&D Officer | Option Exercise | A | 21.79 | 71,550 | 1,559,075 | 71,550 | |
| Dec 16 2019 | NKTR | NEKTAR THERAPEUTIC ... | Zalevsky Jonathan | Chief R&D Officer | Grant | A | 0.00 | 40,150 | 0 | 331,847 | 291.7 K to 331.8 K (+13.76 %) |
| Dec 16 2019 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | A | 21.79 | 11,800 | 257,122 | 11,800 | |
| Dec 16 2019 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Option Exercise | A | 21.79 | 26,600 | 579,614 | 26,600 | |
| Dec 16 2019 | NKTR | NEKTAR THERAPEUTIC ... | Thomsen Jillian B. | SVP & Chief Account ... | Grant | A | 0.00 | 14,900 | 0 | 175,480 | 160.6 K to 175.5 K (+9.28 %) |
| Dec 16 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | A | 21.79 | 44,600 | 971,834 | 44,600 | |
| Dec 16 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | A | 21.79 | 167,650 | 3,653,094 | 167,650 | |
| Dec 16 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Grant | A | 0.00 | 94,100 | 0 | 393,319 | 299.2 K to 393.3 K (+31.45 %) |
| Dec 16 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Option Exercise | A | 21.79 | 29,000 | 631,910 | 29,000 | |
| Dec 16 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Option Exercise | A | 21.79 | 71,550 | 1,559,075 | 71,550 | |
| Dec 16 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Grant | A | 0.00 | 40,150 | 0 | 259,159 | 219 K to 259.2 K (+18.33 %) |
| Dec 04 2019 | NKTR | NEKTAR THERAPEUTIC ... | NORTHCOTT JOHN | SVP & Chief Commerc ... | Option Exercise | A | 19.48 | 200,000 | 3,896,000 | 200,000 | |
| Dec 04 2019 | NKTR | NEKTAR THERAPEUTIC ... | NORTHCOTT JOHN | SVP & Chief Commerc ... | Grant | A | 0.00 | 200,000 | 0 | 200,000 | 0 to 200 K |